Toll-Like Receptor 2 Signaling Protects Mice from Tumor Development in a Mouse Model of Colitis-Induced Cancer

• Emily L. Lowe,

  Affiliation Division of Pediatric Infectious Diseases and Immunology, Cedars-Sinai Medical Center and David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California, United States of America

  ⨯
• Timothy R. Crother,

  Affiliation Division of Pediatric Infectious Diseases and Immunology, Cedars-Sinai Medical Center and David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California, United States of America

  ⨯
• Shervin Rabizadeh,

  Affiliation Division of Pediatric Gastroenterology, Cedars-Sinai Medical Center and David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California, United States of America

  ⨯
• Bing Hu,

  Affiliation Department of Pathology, Cedars-Sinai Medical Center and David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California, United States of America

  ⨯
• Hanlin Wang,

  Affiliation Department of Pathology, Cedars-Sinai Medical Center and David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California, United States of America

  ⨯
• Shuang Chen,

  Affiliation Division of Pediatric Infectious Diseases and Immunology, Cedars-Sinai Medical Center and David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California, United States of America

  ⨯
• Kenichi Shimada,

  Affiliation Division of Pediatric Infectious Diseases and Immunology, Cedars-Sinai Medical Center and David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California, United States of America

  ⨯
• Michelle H. Wong,

  Affiliation Inflammatory Bowel Disease Center & Immunobiology Research Institute, Burns and Allen Research Institute, Cedars-Sinai Medical Center and David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California, United States of America

  ⨯
• Kathrin S. Michelsen ,

  Contributed equally to this work with: Kathrin S. Michelsen, Moshe Arditi

  * E-mail: kathrin.michelsen@cshs.org (KSM); moshe.arditi@cshs.org (MA)

  Affiliation Inflammatory Bowel Disease Center & Immunobiology Research Institute, Burns and Allen Research Institute, Cedars-Sinai Medical Center and David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California, United States of America

  ⨯
• Moshe Arditi

  Contributed equally to this work with: Kathrin S. Michelsen, Moshe Arditi

  * E-mail: kathrin.michelsen@cshs.org (KSM); moshe.arditi@cshs.org (MA)

  Affiliation Division of Pediatric Infectious Diseases and Immunology, Cedars-Sinai Medical Center and David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California, United States of America

  ⨯